Specific advancements:
Targeted Therapies:
Zolbetuximab, a new drug targeting a specific protein (CLDN18.2), has shown promise in extending survival for patients with advanced gastric or gastroesophageal junction cancer.
Immunotherapies:
Combination therapies using immunotherapies like nivolumab with other drugs like anlotinib are showing positive results in advanced stomach cancer.
New Chemotherapy Approach (HIPEC):
A new chemotherapy approach called hyperthermic intraperitoneal chemotherapy (HIPEC) delivers heated chemotherapy directly to the abdomen, targeting cancer cells in that region.
Other Advancements:
The use of chemotherapy "spray" and targeted therapies like trastuzumab (Herceptin) are also being explored for stomach cancer treatment.